CLADRIBINE(2-CDA) AND CYTARABINE(ARA-C) IS AN EFFECTIVE SALVAGE REGIMEN IN REFRACTORY/RELAPSED ACUTE MYELOID LEUKAEMIA IN CHILDREN

被引：0
|
作者：
Chinnaswamy, Girish [1 ]
Prasad, Maya [1 ]
Dwivedi, Pankaj [1 ]
Patil, Vijay [1 ]
Arora, Brijesh [1 ]
Banavali, Shripad [1 ]
机构：
[1] Tata Mem Hosp, Dept Med Oncol Pediat, Mumbai 400012, Maharashtra, India
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1040 / 1040
页数：1
相关论文
共 50 条
  • [1] Interim analysis of cytarabine (ara-C) and cladribine (2-CDA) combination therapy in acute myeloid leukemia (AML).
    Radomski, KM
    Gandhi, V
    Srivastava, DK
    Razzouk, BI
    Behm, FG
    Plunkett, W
    Pui, CH
    Rubnitz, JE
    Ribeiro, RC
    BLOOD, 2000, 96 (11) : 327A - 327A
  • [2] SUCCESSFUL SALVAGE TREATMENT WITH CLOFARABINE AND CYTARABINE (ARA-C) IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
    Malato, A.
    Santoro, A.
    Felice, R.
    Magrin, S.
    Turri, D.
    Di Bella, R.
    Salemi, D.
    Acquaviva, F.
    Scime, R.
    Fabbiano, F.
    HAEMATOLOGICA, 2013, 98 : 31 - 31
  • [3] CURATIVE EFFECT AND SAFETY OF 2-CDA, ARA-C AND G-CSF COMBINED TREATMENT FOR RELAPSED REFRACTORY ACUTE MYELOID LEUKEMIA
    Zhang, Xiaoxiang
    Chen, Ying
    Shou, Lihong
    Yang, Jianghua
    ACTA MEDICA MEDITERRANEA, 2021, 37 (01): : 163 - 167
  • [4] Cladribine (2-CDA) in combination with Ara-C. Etoposide and G-CSF is effective in secondary or relapsed acute myeloid leukemia (AML).
    Krieger, O
    Kasparu, H
    Girschikofsky, M
    Lutz, D
    BLOOD, 1996, 88 (10) : 3422 - 3422
  • [5] 2 chlorodeoxyadenosine (2-CdA) and cytarabine (ara-C) combination is effective and safe in idiopathic hypereosinophilic syndrome (HES).
    Jabbour, E
    Verstovsek, S
    Gandhi, V
    Cortes, J
    Giles, F
    Koller, C
    O'Brien, S
    Plunkett, W
    Garcia-Manero, G
    Jackson, E
    Kantarjian, H
    Andreeff, M
    BLOOD, 2004, 104 (11) : 274B - 274B
  • [6] CLOFARABINE IN COMBINATION WITH CYTARABINE (ARA-C) FOR TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA IN ADULT PATIENTS
    Malato, A.
    Santoro, A.
    Magrin, S.
    Felice, R.
    Turri, D.
    Di Bella, R.
    Salemi, D.
    Acquaviva, F.
    Scime, R.
    Fabbiano, F.
    HAEMATOLOGICA, 2012, 97 : 502 - 503
  • [7] Circumvention of cytarabine (Ara-C) resistance by 2-chloro-deoxyadenosine (2-CdA) in pediatric acute myeloid (AML) and acute lymphoblastic (ALL) leukemia: An in vitro study.
    Zwaan, CM
    Kaspers, GJL
    Pieters, R
    Huismans, DR
    Van Wering, ER
    Janka-Schaub, GE
    Creutzig, U
    Henze, G
    Veerman, AJP
    BLOOD, 2000, 96 (11) : 307A - 307A
  • [8] ARA-C AND AMSA FOR TREATMENT OF RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA
    JAGER, U
    LECHNER, K
    SCHWARZINGER, I
    BETTELHEIM, P
    BOGNAR, H
    GEISSLER, K
    HAAS, O
    HINTERBERGER, W
    KOS, M
    LEITHA, T
    NEUMANN, E
    PANZER, S
    POLLAK, C
    BLUT, 1986, 53 (03): : 145 - 145
  • [9] ARA-C AND AMSA IN THE THERAPY OF RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA
    JAGER, U
    WIENER KLINISCHE WOCHENSCHRIFT, 1986, 98 (17) : 589 - 589
  • [10] Etoposide and cytarabine as an effective and safe cytoreductive regimen for relapsed or refractory acute myeloid leukemia
    Nair, G.
    Karmali, R.
    Gregory, S. A.
    Shammo, J. M.
    Fung, H. C.
    Jimenez, A.
    Venugopal, P.
    Larson, M. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345